Publications by authors named "George Lowell"

Claim this Profile
B
Back to the future: Immunization with M-001 prior to trivalent influenza vaccine in 2011/12 enhanced protective immune responses against 2014/15 epidemic strain.
George H Lowell, Sagit Ziv, Svetlana Bruzil, Ron Babecoff, Tamar Ben-Yedidia

Vaccine· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranasal Protollin-formulated recombinant SARS S-protein elicits respiratory and serum neutralizing antibodies and protection in mice.
Mary C Hu, Taff Jones, Richard T Kenney, Dale L Barnard, David S Burt, George H Lowell

Vaccine· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranasal Protollin/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection.
Taff Jones, Jeffrey J Adamovicz, Sonya L Cyr, Chris R Bolt, Nathalie Bellerose, George H Lowell

Vaccine· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a Proteosome -trivalent inactivated influenza vaccine, given nasally to healthy adults.
Joanne M Langley, Scott A Halperin, Shelly McNeil, Bruce Smith, Taff Jones, George H Lowell

Vaccine· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranasal administration of a proteosome-influenza vaccine is well-tolerated and induces serum and nasal secretion influenza antibodies in healthy human subjects.
John Treanor, Carrie Nolan, Diane O'Brien, David Burt, George Lowell

Vaccine· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward the development of an antidisease, transmission-blocking intranasal vaccine for group a streptococcus.
Michael R Batzloff, Huaru Yan, Mark R Davies, Jon Hartas, George H Lowell

J Infect Dis· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel intranasal Protollin-based measles vaccine induces mucosal and systemic neutralizing antibody responses and cell-mediated immunity in mice.
Sophie Chabot, Angela Brewer, George Lowell, Martin Plante, Sonya Cyr

Vaccine· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protollin: a novel adjuvant for intranasal vaccines.
Taff Jones, Sonya Cyr, Francine Allard, Nathalie Bellerose, George H Lowell

Vaccine· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranasal immunization with multivalent group A streptococcal vaccines protects mice against intranasal challenge infections.
Mary A Hall, Steven D Stroop, Mary C Hu, Michael A Walls, Mark A Reddish, George H Lowell

Infect Immun· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A nasal Proteosome influenza vaccine containing baculovirus-derived hemagglutinin induces protective mucosal and systemic immunity.
Taff Jones, Francine Allard, Sonya L Cyr, Steven P Tran, Martin Plante, George H Lowell

Vaccine· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis